HPLC determination of tetroxoprim and sulphadiazine in pharmaceutical dosage forms and biological fluids
- 1 January 1989
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 7 (1) , 57-65
- https://doi.org/10.1016/0731-7085(89)80067-6
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Trimethoprim, Metioprim, Tetroxoprim, and RO 10‐5970 in Canine BoneActa Pharmacologica et Toxicologica, 1982
- Activity in vitro of tetroxoprim-sulphadiazineJournal of Antimicrobial Chemotherapy, 1979
- The development of the diaminopyrimidinesJournal of Antimicrobial Chemotherapy, 1979
- Tetroxoprim - a new inhibitor of bacterial dihydrofolate reductaseJournal of Antimicrobial Chemotherapy, 1979
- Treatment of urinary infections with tetroxoprim/sulphadiazineJournal of Antimicrobial Chemotherapy, 1979
- Biotransformation of tetroxoprim in manJournal of Antimicrobial Chemotherapy, 1979
- Pharmacokinetics of tetroxoprim and sulphadiazine in various speciesJournal of Antimicrobial Chemotherapy, 1979
- Activity of metronidazole against Escherichia coli in experimental infra-abdominal sepsisJournal of Antimicrobial Chemotherapy, 1979
- Trimethoprim R plasmids isolated daring long-term treatment of urinary tract infection with co-trimoxazoleJournal of Antimicrobial Chemotherapy, 1979
- Activity of HR 756 against Haemophilus influenza, Bacteroides fragilis and Gram negative rodsJournal of Antimicrobial Chemotherapy, 1979